Tuesday 4 November 2014

Spinal Non-fusion Devices Transforming Healthcare Industry, 2013 - 2019

Posted on 22:09 by Alina Martin
The introduction of spinal non-fusion devices has revolutionized the diagnosis and treatment of spine injuries and improved patient outcome to a great extent. Spinal non-fusion devices allow patients to retain stability, movement and flexibility of the spine to some extent. Owing to the wide range of benefits, the global spinal non-fusion devices market has witnessed significant growth.
Spinal non-fusion devices are used to diagnose, test, and treat a number of ailments related to the spine. These include spinal tumors, disc herniation, spondylosis, kyphosis, spondylolisthesis, lordosis, abnormal curvature of the spine, osteoarthritis, osteoporosis, scoliosis, stenosis, vertebral fractures, ankylosing spondylitis, traumatic spinal injuries, arthritis, and rheumatoid arthritis.
Read More :- http://www.transparencymarketresearch.com/spinal-non-fusion-devices-market.html
Highly-advanced technologies driving the spinal non-fusion devices market
The remarkable growth of the global spinal non-fusion devices market has been largely attributed to technological advancements, innovations, and emerging products. In addition to this, growing geriatric population, rising incidences of obesity, and increasing demand for minimally invasive surgeries also fuel the growth of the spinal non-fusion devices market. Increasing approvals for new and innovative products in the field of spinal surgery has not only promoted awareness regarding the gravity of back pain, but also instilled a sense of confidence among patients with regards to motion-preserving technologies. This in turn has spurred the adoption rate for spinal non-fusion devices. The rising competition and high growth in emerging nations such as India, China, and Brazil has fuelled the spinal non-fusion devices market in recent years.
On the other hand, unstable and stringent reimbursement policies and rigid government regulations in regions such as Japan is expected to hamper the growth of the spinal non-fusion devices market.
Rise in obesity fuelling the spinal non-fusion devices market in North America
North America is the largest market for spinal non-fusion devices and is also projected to be the fastest-growing regional segment during the forecast period of 2013-2019, registering a double-digit CAGR. Data states that nearly 50% of the total population in the U.S. above the age of 40 suffers from degenerative disc disease, which drives the spinal non-fusion devices market. Other factors that support the North American market are technological advancements, adoption of new technologies to treat spinal ailments, and growing prevalence of obesity.
Europe is the second-largest market for spinal non-fusion devices owing to increasing introduction of safer and more efficient devices.
Asia-Pacific and the Rest of the World region have been witnessing considerable growth in recent years. The spinal non-fusion devices market in countries such as South Korea, Australia, China, India, and Brazil is driven by factors such as availability of technologies, development of healthcare facilities and infrastructure, consumer awareness regarding importance of spinal surgery and new-age devices, growing population, and favourable reimbursements.
However, conservative surgery approach and strict regulatory approvals are expected to stall the growth of the spinal non-fusion devices market in some Asian countries.
Spinal non-fusion devices: Areas of segmentation
The overall market for spinal non-fusion devices can be segmented on the basis of geography and technology. Geographically, the global market is divided into North America, Europe, Asia-Pacific, and Rest of the World. On the basis of technology, the market for spinal non-fusion devices is segmented into artificial discs, nuclear disc prostheses, dynamic stabilization devices, and annulus repair devices. Dynamic stabilization devices are bifurcated into facet arthoplasty devices and interspinous process decompression devices. Artificial discs include artificial discs for lumbar and cervical vertebrae.
Competitive landscape of the worldwide market for spinal non-fusion devices
The spinal non-fusion devices market is immensely competitive with a number of top players operating within the industry. Some of the leading participants of the global spinal non-fusion devices market are Raymedica, Vertebral Technologies, Cryo Life, Zimmer Spine, Pioneer Surgical technologies, Arthro Kinetics, Medtronic, DePuy Spine, NP Solutions, Replication Medical, and Synthes Spine.
Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2137
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Browse Market Research Blogs:

Posted in , , , | No comments

Growing Benefits and Popularity of Optical Coherence Tomography 2013- 2019

Posted on 22:08 by Alina Martin

Optical coherence tomography is a non-invasive diagnostic procedure most commonly used in the field of ophthalmology. However, due to its technological benefits and in-depth visualization, optical coherence tomography finds extensive use in other medical disciplines such as dermatology, oncology, and endoscopic diagnosis.
One of the major reasons for the growth of the optical coherence tomography market is growing geriatric population. According to the World Health Organization, 13% of the global population in 2010 was constituted by the elderly, and this is expected to grow to over 50% by 2020.
Read More :- http://www.transparencymarketresearch.com/optical-coherence-tomography-market.html
Optical coherence tomography: Areas of segmentation
The optical coherence tomography market is highly fragmented and can be categorized on the basis of parameters such as geography, applications, volumetric images used, device type, and technology.
Region-wise, the global optical coherence tomography market is divided into North America, Europe, Asia-Pacific, and Rest of the World. The application areas of optical coherence tomography are diagnosis of conditions such as central serous retinopathy, macular hole, age-related macular degeneration, macular edema, macular pucker, vitreomacular traction, preretinal membranes, and diabetic retinopathy. The three main types of volumetric images used in optical coherence tomography are raster or rectangular volume scan, annular volume scan, and radial volume scan. On the basis of technology, the overall market can be segmented into frequency domain optical coherence tomography (FDOCT), time domain optical coherence tomography (TDOCT), and spatially encoded frequency domain optical coherence tomography (which includes Fourier domain optical coherence tomography (FDOCT) and spectral domain optical coherence tomography (SDOCT)). The major types of optical coherence tomography devices used for diagnosis include handheld OCT devices, catheter-based OCT devices, tabletop OCT devices, and Doppler OCT devices.
Optical coherence tomography markets in Asia-Pacific and Latin America expected to thrive during forecast period
Globally, North America leads the overall optical coherence tomography market, primarily driven by the growing geriatric population. Based on information provided by the U.S. Census Bureau, in 2010, the number of people above the age of 65 years in the U.S. was 22 to every 100 people. This number is expected to rise to 35 by 2020. Aging population is more susceptible to ophthalmic disorders such as age-related macular degeneration, diabetic retinopathy and macular edema, thereby increasing the demand for optical coherence tomography. In addition to this, the rising number of research and academic facilities in the U.S. has also fuelled the growth of the market in this region. Europe follows North America in terms of optical coherence tomography market size, once again due to aging population and rising number of age-related disorders. Although the growth in these two regions has been remarkable so far, forecast suggests that the growth of the optical coherence tomography market in the near future will be slow owing to saturation of the market and economic slowdown.
On the other hand, optical coherence tomography markets in Asia-Pacific and Latin America are still untapped and possess immense potential for growth. Emerging nations such as Japan, China, India, and Brazil have been witnessing greater economic development along with rising awareness regarding ophthalmic ailments. This has had a huge impact on the optical coherence tomography market in these two regions. Other factors that have led to the growth of the Asia-Pacific and Latin American markets are higher disposable incomes, growing investments in biotechnology and pharmaceutical industries, and increasing acceptance of advanced medical and imaging technologies.
Oligopolistic nature of the global optical coherence tomography market
The worldwide market for optical coherence tomography is extremely concentrated with the top few companies enjoying more than half of the total market share. However, severe competition among mid-sized and small companies has begun posing a threat to the industry leaders. Some of the notable participants of the optical coherence tomography market are Novacam Technologies Inc., Canon, Inc., Agfa Healthcare, Bioptigen, Inc., PerkinElmer, Inc., Headwall Photonics, OPTOPOL Technology S.A., Heidelberg Engineering, Inc., Imalux Corporation, Topcon Medical Systems, Inc., Carl Zeiss Meditec AG, Michelson Diagnostics, St. Jude Medical, Inc., Thorlabs Inc., and Volcano Corporation.
According a market intelligence company, the global optical coherence tomography market is expected to grow to over US$1 billion in the next couple of years.
Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2209
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Browse Market Research Blogs:

Posted in , , | 1 comment

Global Dental Laboratories Market – Types of Dental Fixtures, Global Market Outlook, and Key Market Trends

Posted on 22:05 by Alina Martin

The global dental laboratories market is currently witnessing surge in demand for dental prosthetics and other types of restoratives. An establishment or body that carries out specialized procedures pertaining to dental treatment without any direct contact with the dentist or the patient is known as a dental laboratory. Dental laboratories are engaged in developing dental implant crowns, dentures, crowns, and other miscellaneous dental restorations.
The global dental laboratories market is primarily driven by factors like a growing geriatric population, rising demand for better and improved dental aesthetics, and greater purchasing power of the baby boomer generation. Dental technologists and laboratory technicians play a crucial role in the working of dental laboratories. There are strategic contracts between dental laboratories and other bodies that purchase their dental products. These dental products are mainly purchased by various industries, patients, and several pharmaceutical companies.
Read More :- http://www.transparencymarketresearch.com/dental-laboratories-market.html
On the global platform, the largest market for dental laboratories is the United States. The largest share in the global dental laboratories market is held by the US. The dental laboratories market in the US is characterized by outsourcing.
The Growth Drivers and Inhibitors Prevailing in the Global Dental Laboratories Market
Some of the prominent factors that are expected to fuel the global dental laboratories market are the growing population that is increasingly availing dental services, tooth implants, and the introduction of innovative and effective technologies in the field of dentistry like cosmetic dental procedures. Technological innovations enable the operators to bring down the manufacturing costs. This, as a result gives a boost to the demand in the global dental laboratories market.
Moreover, as mentioned earlier the rising geriatric population is also a prominent factor driving the global dental laboratories market. The growing demand for dental services can be owed to the application of computer aided manufacturing, and computer aided design.
The dental laboratories market in the developed countries is witnessing greater health awareness amongst the masses, greater per capital expenditure on health services, and higher demand for improved dental aesthetics. Also, high demand for dental aesthetics is also being observed in the emerging economies as well.
Unaffordable dental surgeries are the main challenges facing the global dental laboratories market. This directly affects the demand in the global dental laboratories market.
North America – Key Player in the Global Dental Laboratories Market
The global dental laboratories market is led by North America since this region is dominated by innumerable domiciled organizations that are engaged in developing and establishing dental laboratories. The National Association of Dental Laboratories situated in North America essentially deals with commercial dental laboratories. Also, North America has several cases of dental problems which is also a prominent factor driving the dental laboratories market in this region. There were several cases of oral cancer reported in the year 2014 in North America. Such a factor not only increases the demand for dental services but also creates enough scope for further research and development in the field of dentistry and dental health.
The North American dental laboratories market is then followed by European dental laboratories market in terms of market share and revenue. Availability of advanced dental care technologies for treating problems like tooth erosion, oral cancer, gum diseases, and the availability of several treatment options are the prime factors that drive the European dental laboratories market.
A common factor driving the global dental laboratories market is the rising geriatric population all across the globe.
An emerging market in the global dental laboratories industry is the Asia Pacific which is driven by high awareness about dental health among the population. Furthermore, it is expected that the dental laboratories market will get a major boost in the forthcoming years due to increasing income levels, and the subsequent rising expenditure by people on dental procedures and surgeries.
Some of the key players operating in the global dental laboratories market include Utah Valley
Dental Lab, Attenborough iDent Dental Lab, National Dentex Corp., 1st Dental Laboratories Plc., Lord’s Dental Studio, Knight Dental Design, Southern Craft Dental Laboratory, Dental Services Group, and Champlain Dental Laboratory.
Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2308
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Browse Market Research Blogs:

Posted in , , , | No comments

Global Bone Morphogenetic Protein Market – Growth Drivers and Inhibitors, and Market Trends

Posted on 22:01 by Alina Martin

Bone morphogenetic protein refers to multifunctional growth factors that play a crucial role in limb development, repair of cartilage, and repairing early fracture. Till now, about twenty different bone morphogenetic proteins have been identified. Each of these bone morphogenetic proteins exhibits varying degrees of tissue stimulating characteristics.
Bone morphogenetic proteins play a significant role in bone augmentation and bone healing since they ensure rapid healing of fractured bones. The roles played by these proteins have most importantly been observed in spinal fusion. There is a greater possibility of bone morphogenetic proteins being used in patients who are either undergoing complicated spinal fusion procedures, or those patients who have previously undergone surgery.
Read More :- http://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html
Orthopedic researches primarily aim at developing techniques for promoting rapid bone reconstruction and make them functionally stronger. Recent orthopedic research and studies have shown that bone morphogenetic proteins like rhBMP-2 have the capacity to stimulate a patient’s cells to create more bone. Bone morphogenetic protein is especially beneficial for those patients who are undergoing spinal fusion techniques since this protein eliminates the need for bone transplantation from the pelvis.
Importance and Significance of the Bone Morphogenetic Protein in the Field of Orthopedics
Almost one third of the total spinal procedures taking place worldwide are incorporating bone morphogenetic proteins. The popularity of growth stimulating spinal cages is being observed in spinal surgeries. The primary advantage of incorporating bone morphogenetic proteins in orthopedic procedures is that it does not rely on donated human tissue. The popularity and efficacy of the bone morphogenetic protein is gaining much momentum because these days doctors and physicians are keeping up with the latest developments taking place in the field of orthopedic medicine.
Moreover, bone morphogenetic proteins ensure faster bone healing. The bone morphogenetic protein market is witnessing growth due to rising cases of fusion failure via the conventional methods. It is also anticipated that bone graft substitutes will be replaced with bone morphogenetic proteins in the years to come.
The global bone morphogenetic protein market will be expanding significantly in the forthcoming years owing to greater number of spinal fusion procedures. Rising cases of bone fractures; especially in the developing economies is a prominent factor that drives the global bone morphogenetic protein market.
Higher incidence of spinal anomalies, sedentary lifestyle of the modern day generation, and a growing global geriatric population are some of the main factors that fuel the global bone morphogenetic protein market.
Problems Prevailing in the Bone Morphogenetic Protein Market and the Future of this Market
A stark problem facing the global morphogenetic bone market is the high price of the products available in the market. This is one of the main factors that will inhibit the growth of the bone morphogenetic protein market in the developing economies. Another factor that magnifies the problem is the issue of unfavorable reimbursements. These problems have to be dealt with soon, in order to ensure effective market capitalization.
Currently, the prices of bone morphogenetic proteins are prohibitively high since their production requires a very expensive type of mammalian cell. The development of its inexpensive alternatives is a very cumbersome and a complex process that would entail European and FDA approval in order to prove its clinical efficacy and safety. Surgeons are generally hesitant about using bone morphogenetic proteins because they are quite expensive.
There are several biocompatibility issues also with regard to bone morphogenetic proteins. Bone morphogenetic proteins are found naturally in the human body; however, high concentration of these proteins poses several carcinogenic and immunological problems. Also, many a times bone morphogenetic proteins lead to excess bone growth in locations apart from the site of treatment.
According to industry analysts, the future of the global bone morphogenetic protein market relies significantly on the market players adopting intensive strategies that aim at research and development, end-user awareness, technology, and business ventures like mergers and acquisitions.
Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2308
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Browse Market Research Blogs:

Posted in , , , , | No comments

Thursday 7 August 2014

Rubella Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Posted on 22:13 by Alina Martin
Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Rubella Diagnostic Testing Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Rubella or German measles is a contagious and acute viral infection caused by the rubella virus. Generally, rubella infection occurs most often in young adults and children. While the rubella infection is typically mild in children, this disease has serious consequences in pregnant women causing congenital defects and fetal death.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/rubella-diagnostic-testing-market.html
Some of the diagnostic testing techniques usually adopted for the diagnosis of rubella are as follows:
  • Clinical evaluation
  • Serological testing
  • Immunoassays
  • Monoclonal antibodies
  • Latex slide agglutination test
  • Flow cytometry
At present, there is no standard drug therapy available for treating rubella. However, MMR vaccine, which is an immunization vaccine, is administered to children for protecting against measles, mumps, and rubella. The goals of medications given to the patients are only to prevent complications and to reduce morbidity.
In terms of geography, Europe is the leading market in rubella diagnostic testing market due to the high susceptibility to rubella. It has been stated that, as of 2004, the U.S. was declared free of rubella and the transmission of the rubella virus was halted across the regions of the Americas in 2009. Furthermore, on January 2014, the PAHO (Pan American Health Organization) and WHO (World Health Organization) declared the Latin American country, Colombia free of rubella. However, it has been observed, epidemics of rubella still occur in developing regions such as South East Asia and Africa, where the vaccine for rubella is not available or accessible. The countries with the largest number of cases in 2012 were Syria, Tajikistan, Macedonia, Timor-Leste and Thailand.
Some of the primary factors driving the growth of rubella diagnostic testing market are low awareness rate among population and introduction of advance point of care diagnostic technologies. For instance, Bio-Rad Laboratories, Inc., a global company engaged in the development and commercialization of clinical diagnostic and life science research products introduced BioPlex 2200 MMRV (Measles, Mumps, Rubella, and Varicella-Zoster Virus) IgG kit for better diagnosis and prevention of these diseases. This kit is designed to provide simultaneous results for the four diseases i.e. Measles, Mumps, Rubella, and Varicella-Zoster Virus (chicken pox). Thus, the introduction of promising point of care diagnostic kits in this market is likely to boosts the overall rubella diagnostic testing market due to the high success and effectiveness rate of the potential molecules. Furthermore, increasing government support for developing novel therapies and vaccines; along with high research and development initiatives on the development of advance diagnostic techniques are expected to fuel the growth of this market. In addition, technological breakthrough such as microfluidic point of care diagnostic kits and increased focus on retaining superior quality of life are some of the factors that might contribute to the growth of this market. However, rise in overall healthcare expenditure and product availability are some of the market-restraining factors that might hinder the growth of the rubella diagnostic testing market in the near future.
At present, the rubella diagnostic testing market is an burgeoning market venture; specifically in regions such as Africa and South East Asia due to the low rate of vaccine coverage in these regions. However, at present this market is highly fragmented owing to the involvement of many established and emerging players. Some of the key players engaged in this market are Abbott Laboratories, Beckman Coulter Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Ortho Clinical Diagnostics and Siemens AG, amongst others.
Read More Reports on Medical Devices Markets: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2935
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
Followed LinkedIn :-https://www.linkedin.com/today/post/article/20140808045047-349336221-rubella-diagnostic-testing-market-2014-2020
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY — 12207
United States
Tel: +1-518-618-1030
USA — Canada Toll Free 866-552-3453

Browse Market Research Blogs:

Posted in , , , | No comments

Monday 7 July 2014

Medical Image Processing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020

Posted on 23:03 by Alina Martin
Medical Image Processing Market
Medical imaging refers to the visualization of the body parts, organs, tissues or cells for clinical diagnosis, disease monitoring and treatment. The imaging techniques used in medical devices include variety of modern equipments in the field of optical imaging, nuclear imaging, radiology and other image-guided intervention. The radiological method renders anatomical and physiological of the human body at a very high spatial and temporal resolution. The radiology discipline covers methods such as ultrasound, CT scan, X-ray, MRI and other similar devices. Whereas, the optical imaging techniques include devices such as optical coherence tomography (OCT), which helps in revealing abnormalities at cellular level with the help of optical tracers for specific tumor cells.
OCT techniques are yet at early stages of development and are likely to uplift the medical imaging market in coming years. Nuclear imaging techniques such as PET and SPECT display remarkable details with respect to metabolism, physiology and molecular function. The major post processing work include activities such as, image reconstruction, image processing, 3D view generation, computer-aided detection, and quality control.
With the increasing development in medical research produces a continuous stream of knowledge about disease processes or stages, new therapeutic targets and complex relationship between a person’s genome and his and her related risk for diseases. Medical imaging can now play a central and vital role in global healthcare systems as it continues to improve patient outcomes and cost effective healthcare diagnostic for almost all disease and deformity class. Traditionally, medical imaging was considered as a tool for non-invasive mapping for recognition and localization of disease process. 
Owing to technological advancements, a wide variety of new medical imaging techniques and methods produce important biological information about molecular biology, physiology, biochemistry, organ function, metabolism, and functional genomics. Furthermore, the medical imaging which many think are only used in diagnostic procedures are now even used for treatment processes such as coronary angioplasty which is used for treating aortic aneurysm and stoppage of cerebral aneurysm bleedings.
Some of the major drivers for the medical imaging processes include miniaturization or portability of devices such as X-Rays, ultrasound devices which come in handheld device forms that enhance the reach and optimization of devices to rural, disaster sites, and even in ambulances which eventually save time for both patients as well as the physicians in case of emergencies. 3D imaging techniques are another opportunity area in the medical image processing market. However, such technically sophisticated devices are confined majorly to the developed economic regions due to lack of pooper budget allocation from government and regulatory bodies.
The major restraints to the global medical image processing market include intense competition from local, lack of skilled radiologists especially in the emerging market and developing market and lack of proper medical reimbursement scenario. Despite such issue, the emerging economies are likely to be the fastest growing markets in the coming years due to substantial public and private investments in development of healthcare infrastructure and rise in disposable income among the middle class population.
Some of the prominent players in the global medical image processing market include Siemens Healthcare, Philips Healthcare, GE Healthcare, Toshiba Medical Systems Corp., Toshiba America Medical Systems, Rcadia Medical Imaging Ltd., TomTec Imaging Systems GmbH, Calgary Scientific Inc., Riverain Medical Group LLC among others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted in , , , | No comments
Subscribe to: Posts (Atom)